Chrome Extension
WeChat Mini Program
Use on ChatGLM

Abstract GS3-01: GS3-01 EMERALD Phase 3 Trial of Elacestrant Versus Standard of Care Endocrine Therapy in Patients with ER+/HER2- Metastatic Breast Cancer: Updated Results by Duration of Prior CDK4/6i in Metastatic Setting

Cancer Research(2023)

Cited 18|Views61
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined